TTNP Titan Pharmaceuticals Inc

USD 4.59 +0.10 ( +2.23%)
Icon

Titan Pharmaceuticals Inc (TTNP) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 4.59

+0.10 (+2.23%)

USD 3.38M

9.86K

N/A

N/A

Icon

TTNP

Titan Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 4.59
+0.10 ( +2.23%)
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.38M

N/A

USD 4.59

Titan Pharmaceuticals Inc (TTNP) Stock Forecast

N/A

Based on the Titan Pharmaceuticals Inc stock forecast from 0 analysts, the average analyst target price for Titan Pharmaceuticals Inc is not available over the next 12 months. Titan Pharmaceuticals Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Titan Pharmaceuticals Inc is Bearish, which is based on 1 positive signals and 5 negative signals. At the last closing, Titan Pharmaceuticals Inc’s stock price was USD 4.59. Titan Pharmaceuticals Inc’s stock price has changed by -5.56% over the past week, +25.75% over the past month and -31.68% over the last year.

No recent analyst target price found for Titan Pharmaceuticals Inc
No recent average analyst rating found for Titan Pharmaceuticals Inc

Company Overview Titan Pharmaceuticals Inc

Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.

https://www.titanpharm.com

10 East 53rd St., New York, NY, United States, 10022

0

December

USD

USA

Adjusted Closing Price for Titan Pharmaceuticals Inc (TTNP)

Loading...

Unadjusted Closing Price for Titan Pharmaceuticals Inc (TTNP)

Loading...

Share Trading Volume for Titan Pharmaceuticals Inc Shares

Loading...

Compare Performance of Titan Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for TTNP

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Titan Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.29 (-0.30%) USD128.84B 32.57 255.95

Frequently Asked Questions About Titan Pharmaceuticals Inc (TTNP) Stock

Stock Target Advisor's fundamental analysis for Titan Pharmaceuticals Inc's stock is Bearish.

Unfortunately we do not have enough data on TTNP's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on TTNP's stock to indicate what its average analyst target is.

TTNP stock's Price/Earning ratio is 13.80. Our analysis grades TTNP stock's Price / Earning ratio at F. This means that TTNP stock's Price/Earning ratio is above 64% of the stocks in the Biotechnology sector in the NSD exchange. Based on this TTNP may be a overvalued for its sector.

The last closing price of TTNP's stock was USD 4.59.

The most recent market capitalization for TTNP is USD 3.38M.

Unfortunately we do not have enough analyst data on TTNP's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Titan Pharmaceuticals Inc's stock.

As per our most recent records Titan Pharmaceuticals Inc has 0 Employees.

Titan Pharmaceuticals Inc's registered address is 10 East 53rd St., New York, NY, United States, 10022. You can get more information about it from Titan Pharmaceuticals Inc's website at https://www.titanpharm.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Titan Pharmaceuticals Inc (TTNP) Stock

Stock Target Advisor's fundamental analysis for Titan Pharmaceuticals Inc's stock is Bearish.

Unfortunately we do not have enough data on TTNP's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on TTNP's stock to indicate what its average analyst target is.

TTNP stock's Price/Earning ratio is 13.80. Our analysis grades TTNP stock's Price / Earning ratio at F. This means that TTNP stock's Price/Earning ratio is above 64% of the stocks in the Biotechnology sector in the NSD exchange. Based on this TTNP may be a overvalued for its sector.

The last closing price of TTNP's stock was USD 4.59.

The most recent market capitalization for TTNP is USD 3.38M.

Unfortunately we do not have enough analyst data on TTNP's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Titan Pharmaceuticals Inc's stock.

As per our most recent records Titan Pharmaceuticals Inc has 0 Employees.

Titan Pharmaceuticals Inc's registered address is 10 East 53rd St., New York, NY, United States, 10022. You can get more information about it from Titan Pharmaceuticals Inc's website at https://www.titanpharm.com.
Loading...